Ipsen announced Wednesday that CEO David Meek has resigned from his position and will assume the chief executive role at FerGene, a new gene therapy company recently launched by Ferring Pharmaceuticals and Blackstone Life Sciences, effective January 14 ne
FerGene, a new gene therapy company formed by Ferring Pharmaceuticals and Blackstone Life Sciences, announced positive results from the pivotal Phase 3 clinical trial ...